Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 2
2003 2
2004 3
2005 3
2006 3
2007 11
2008 8
2009 2
2010 3
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Infectious disease, the innate immune response, and fibrosis.
Meneghin A, Hogaboam CM. Meneghin A, et al. J Clin Invest. 2007 Mar;117(3):530-8. doi: 10.1172/JCI30595. J Clin Invest. 2007. PMID: 17332880 Free PMC article. Review.
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?
Huang SK, Peters-Golden M. Huang SK, et al. Chest. 2008 Jun;133(6):1442-1450. doi: 10.1378/chest.08-0306. Chest. 2008. PMID: 18574287 Free PMC article. Review.
Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.
Ballinger MN, McMillan TR, Moore BB. Ballinger MN, et al. Arch Immunol Ther Exp (Warsz). 2007 Jan-Feb;55(1):1-12. doi: 10.1007/s00005-007-0001-2. Arch Immunol Ther Exp (Warsz). 2007. PMID: 17221337 Free PMC article. Review.
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.
Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, Toews GB, Flaherty KR. Fell CD, et al. Am J Respir Crit Care Med. 2010 Apr 15;181(8):832-7. doi: 10.1164/rccm.200906-0959OC. Epub 2010 Jan 7. Am J Respir Crit Care Med. 2010. PMID: 20056903 Free PMC article.
Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD, Strieter RM. Moore BB, et al. Am J Pathol. 1999 May;154(5):1503-12. doi: 10.1016/S0002-9440(10)65404-1. Am J Pathol. 1999. PMID: 10329603 Free PMC article.
Sex differences in physiological progression of idiopathic pulmonary fibrosis.
Han MK, Murray S, Fell CD, Flaherty KR, Toews GB, Myers J, Colby TV, Travis WD, Kazerooni EA, Gross BH, Martinez FJ. Han MK, et al. Eur Respir J. 2008 Jun;31(6):1183-8. doi: 10.1183/09031936.00165207. Epub 2008 Mar 5. Eur Respir J. 2008. PMID: 18321929 Free article.
Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways.
Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, Thannickal VJ, Horowitz JC, Peters-Golden M. Huang SK, et al. FASEB J. 2009 Dec;23(12):4317-26. doi: 10.1096/fj.08-128801. Epub 2009 Aug 11. FASEB J. 2009. PMID: 19671668 Free PMC article.
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.
Trujillo G, Meneghin A, Flaherty KR, Sholl LM, Myers JL, Kazerooni EA, Gross BH, Oak SR, Coelho AL, Evanoff H, Day E, Toews GB, Joshi AD, Schaller MA, Waters B, Jarai G, Westwick J, Kunkel SL, Martinez FJ, Hogaboam CM. Trujillo G, et al. Sci Transl Med. 2010 Nov 10;2(57):57ra82. doi: 10.1126/scitranslmed.3001510. Sci Transl Med. 2010. PMID: 21068441 Free PMC article.
35 results
Jump to page
Feedback